Gordon Laurie is a professor of cell biology at the University of Virginia and he says the prescription drugs treat only the inflammation, not the cause. He’s been working on this problem for 32 years, and says, he thinks he can fix it.

His drops go to clinical trials in March. If successful, Lacripep, the first drug to treat the cause of dry eyes, could be on the market in four years.